A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune disease. 2005

Peggy P Ho, and Paulo Fontoura, and Michael Platten, and Raymond A Sobel, and Jason J DeVoss, and Lowen Y Lee, and Brian A Kidd, and Beren H Tomooka, and Julien Capers, and Ashish Agrawal, and Rohit Gupta, and Jonathan Zernik, and Michael K Yee, and Byung J Lee, and Hideki Garren, and William H Robinson, and Lawrence Steinman
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, CA 94305, USA.

Targeting pathogenic T cells with Ag-specific tolerizing DNA vaccines encoding autoantigens is a powerful and feasible therapeutic strategy for Th1-mediated autoimmune diseases. However, plasmid DNA contains abundant unmethylated CpG motifs, which induce a strong Th1 immune response. We describe here a novel approach to counteract this undesired side effect of plasmid DNA used for vaccination in Th1-mediated autoimmune diseases. In chronic relapsing experimental autoimmune encephalomyelitis (EAE), combining a myelin cocktail plus IL-4-tolerizing DNA vaccine with a suppressive GpG oligodeoxynucleotide (GpG-ODN) induced a shift of the autoreactive T cell response toward a protective Th2 cytokine pattern. Myelin microarrays demonstrate that tolerizing DNA vaccination plus GpG-ODN further decreased anti-myelin autoantibody epitope spreading and shifted the autoreactive B cell response to a protective IgG1 isotype. Moreover, the addition of GpG-ODN to tolerizing DNA vaccination therapy effectively reduced overall mean disease severity in both the chronic relapsing EAE and chronic progressive EAE mouse models. In conclusion, suppressive GpG-ODN effectively counteracted the undesired CpG-induced inflammatory effect of a tolerizing DNA vaccine in a Th1-mediated autoimmune disease by skewing both the autoaggressive T cell and B cell responses toward a protective Th2 phenotype. These results demonstrate that suppressive GpG-ODN is a simple and highly effective novel therapeutic adjuvant that will boost the efficacy of Ag-specific tolerizing DNA vaccines used for treating Th1-mediated autoimmune diseases.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009185 Myelin Proteins MYELIN-specific proteins that play a structural or regulatory role in the genesis and maintenance of the lamellar MYELIN SHEATH structure. Myelin Protein,Protein, Myelin,Proteins, Myelin
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D004681 Encephalomyelitis, Autoimmune, Experimental An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5) Autoimmune Encephalomyelitis, Experimental,Encephalomyelitis, Allergic,Encephalomyelitis, Experimental Autoimmune,Allergic Encephalomyelitis,Allergic Encephalomyelitis, Experimental,Autoimmune Experimental Encephalomyelitis,Experimental Allergic Encephalomyelitis,Experimental Autoimmune Encephalomyelitis,Encephalomyelitis, Autoimmune Experimental,Encephalomyelitis, Experimental Allergic,Experimental Allergic Encephalomyelitides,Experimental Encephalomyelitis, Autoimmune
D005260 Female Females
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Peggy P Ho, and Paulo Fontoura, and Michael Platten, and Raymond A Sobel, and Jason J DeVoss, and Lowen Y Lee, and Brian A Kidd, and Beren H Tomooka, and Julien Capers, and Ashish Agrawal, and Rohit Gupta, and Jonathan Zernik, and Michael K Yee, and Byung J Lee, and Hideki Garren, and William H Robinson, and Lawrence Steinman
February 2003, Journal of immunology (Baltimore, Md. : 1950),
Peggy P Ho, and Paulo Fontoura, and Michael Platten, and Raymond A Sobel, and Jason J DeVoss, and Lowen Y Lee, and Brian A Kidd, and Beren H Tomooka, and Julien Capers, and Ashish Agrawal, and Rohit Gupta, and Jonathan Zernik, and Michael K Yee, and Byung J Lee, and Hideki Garren, and William H Robinson, and Lawrence Steinman
November 1999, Journal of immunology (Baltimore, Md. : 1950),
Peggy P Ho, and Paulo Fontoura, and Michael Platten, and Raymond A Sobel, and Jason J DeVoss, and Lowen Y Lee, and Brian A Kidd, and Beren H Tomooka, and Julien Capers, and Ashish Agrawal, and Rohit Gupta, and Jonathan Zernik, and Michael K Yee, and Byung J Lee, and Hideki Garren, and William H Robinson, and Lawrence Steinman
April 2002, Clinical immunology (Orlando, Fla.),
Peggy P Ho, and Paulo Fontoura, and Michael Platten, and Raymond A Sobel, and Jason J DeVoss, and Lowen Y Lee, and Brian A Kidd, and Beren H Tomooka, and Julien Capers, and Ashish Agrawal, and Rohit Gupta, and Jonathan Zernik, and Michael K Yee, and Byung J Lee, and Hideki Garren, and William H Robinson, and Lawrence Steinman
January 2000, Current directions in autoimmunity,
Peggy P Ho, and Paulo Fontoura, and Michael Platten, and Raymond A Sobel, and Jason J DeVoss, and Lowen Y Lee, and Brian A Kidd, and Beren H Tomooka, and Julien Capers, and Ashish Agrawal, and Rohit Gupta, and Jonathan Zernik, and Michael K Yee, and Byung J Lee, and Hideki Garren, and William H Robinson, and Lawrence Steinman
November 2018, Virology journal,
Peggy P Ho, and Paulo Fontoura, and Michael Platten, and Raymond A Sobel, and Jason J DeVoss, and Lowen Y Lee, and Brian A Kidd, and Beren H Tomooka, and Julien Capers, and Ashish Agrawal, and Rohit Gupta, and Jonathan Zernik, and Michael K Yee, and Byung J Lee, and Hideki Garren, and William H Robinson, and Lawrence Steinman
January 2016, Mucosal immunology,
Peggy P Ho, and Paulo Fontoura, and Michael Platten, and Raymond A Sobel, and Jason J DeVoss, and Lowen Y Lee, and Brian A Kidd, and Beren H Tomooka, and Julien Capers, and Ashish Agrawal, and Rohit Gupta, and Jonathan Zernik, and Michael K Yee, and Byung J Lee, and Hideki Garren, and William H Robinson, and Lawrence Steinman
December 2000, European journal of immunology,
Peggy P Ho, and Paulo Fontoura, and Michael Platten, and Raymond A Sobel, and Jason J DeVoss, and Lowen Y Lee, and Brian A Kidd, and Beren H Tomooka, and Julien Capers, and Ashish Agrawal, and Rohit Gupta, and Jonathan Zernik, and Michael K Yee, and Byung J Lee, and Hideki Garren, and William H Robinson, and Lawrence Steinman
January 2023, Frontiers in neurology,
Peggy P Ho, and Paulo Fontoura, and Michael Platten, and Raymond A Sobel, and Jason J DeVoss, and Lowen Y Lee, and Brian A Kidd, and Beren H Tomooka, and Julien Capers, and Ashish Agrawal, and Rohit Gupta, and Jonathan Zernik, and Michael K Yee, and Byung J Lee, and Hideki Garren, and William H Robinson, and Lawrence Steinman
May 2021, Cureus,
Peggy P Ho, and Paulo Fontoura, and Michael Platten, and Raymond A Sobel, and Jason J DeVoss, and Lowen Y Lee, and Brian A Kidd, and Beren H Tomooka, and Julien Capers, and Ashish Agrawal, and Rohit Gupta, and Jonathan Zernik, and Michael K Yee, and Byung J Lee, and Hideki Garren, and William H Robinson, and Lawrence Steinman
June 2005, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!